Fig. 5

Comparison of overall survival between patients with and without LT in the low-risk group of the training cohort (A) and validation cohort (C); Comparison of overall survival between patients with and without LT in the high-risk group of the training cohort (B) and validation cohort (D). LT, local treatment for metastatic lesion